Kegeles LS - Search Results

1

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Poels EM, et al. Among authors: kegeles ls. Mol Psychiatry. 2014 Jan;19(1):20-9. doi: 10.1038/mp.2013.136. Epub 2013 Oct 29. Mol Psychiatry. 2014. PMID: 24166406 Review.

2

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.

Kegeles LS, Humaran TJ, Mann JJ. Kegeles LS, et al. Biol Psychiatry. 1998 Sep 15;44(6):382-98. doi: 10.1016/s0006-3223(97)00425-3. Biol Psychiatry. 1998. PMID: 9777167 Free article. Review.

3

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.

Kegeles LS, Zea-Ponce Y, Abi-Dargham A, Rodenhiser J, Wang T, Weiss R, Van Heertum RL, Mann JJ, Laruelle M. Kegeles LS, et al. Synapse. 1999 Mar 15;31(4):302-8. doi: 10.1002/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A. Synapse. 1999. PMID: 10051112 Clinical Trial.

4

PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.

Abi-Dargham A, Simpson N, Kegeles L, Parsey R, Hwang DR, Anjilvel S, Zea-Ponce Y, Lombardo I, Van Heertum R, Mann JJ, Foged C, Halldin C, Laruelle M. Abi-Dargham A, et al. Synapse. 1999 May;32(2):93-109. doi: 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO;2-C. Synapse. 1999. PMID: 10231129

5

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Laruelle M, et al. Biol Psychiatry. 1999 Jul 1;46(1):56-72. doi: 10.1016/s0006-3223(99)00067-0. Biol Psychiatry. 1999. PMID: 10394474 Free article. Review.

6

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.

Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M, Kaufmann CA. Kegeles LS, et al. Psychiatry Res. 2000 May 15;98(3):163-75. doi: 10.1016/s0925-4927(00)00044-5. Psychiatry Res. 2000. PMID: 10821999 Free article.

7

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. Abi-Dargham A, et al. Among authors: kegeles ls. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8104-9. doi: 10.1073/pnas.97.14.8104. Proc Natl Acad Sci U S A. 2000. PMID: 10884434 Free PMC article.

8

In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Slifstein M, Van Heertum RL, Mann JJ, Laruelle M. Parsey RV, et al. Among authors: kegeles ls. J Nucl Med. 2000 Sep;41(9):1465-77. J Nucl Med. 2000. PMID: 10994724 Free article.

9

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M. Kegeles LS, et al. Biol Psychiatry. 2000 Oct 1;48(7):627-40. doi: 10.1016/s0006-3223(00)00976-8. Biol Psychiatry. 2000. PMID: 11032974 Free article. Clinical Trial.

10

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.

Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M. Martinez D, et al. Neuropsychopharmacology. 2001 May;24(5):553-60. doi: 10.1016/S0893-133X(00)00216-5. Neuropsychopharmacology. 2001. PMID: 11282255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters